Go to
JCI Insight
Citations to this article
Hans D. Ochs, … , Starkey D. Davis, Ralph J. Wedgwood
Published December 1, 1971
Citation Information: J Clin Invest. 1971;50(12):2559-2568. https://doi.org/10.1172/JCI106756.
Citation Information: J Clin Invest. 1971;50(12):2559-2568. https://doi.org/10.1172/JCI106756.
Abstract
Immunologic responses to bacteriophage ϕX 174 were studied in 26 patients with immunodeficiency diseases. In eight cases of infantile X-linked agammaglobulinemia, there was prolonged circulation of phage and no detectable antibody response. The remaining 18 patients cleared phage normally and produced antibodies. 10 of these patients made only IgM antibody in spite of repeated immunization; all of these have recurrent respiratory tract infections and require treatment with gamma globulin and antibiotics. Eight patients made both IgM and IgG antibody; they experience either milder or no infections, and only one requires treatment with gamma globulin.
Authors
Hans D. Ochs, Starkey D. Davis, Ralph J. Wedgwood
Total citations by year
| Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1995 | 1994 | 1993 | 1991 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citations: | 2 | 4 | 4 | 2 | 3 | 6 | 11 | 6 | 2 | 3 | 2 | 7 | 5 | 4 | 4 | 5 | 8 | 3 | 1 | 1 | 3 | 4 | 5 | 4 | 3 | 2 | 1 | 2 | 4 | 2 | 5 | 4 | 1 | 3 | 2 | 3 | 7 | 5 | 2 | 1 | 3 | 2 | 2 | 1 | 2 | 1 | 4 | 6 | 2 | 2 | 171 |
Citation information
Citations to this article in year 2017 (2)
| Title and authors | Publication | Year |
|---|---|---|
|
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy
S Schliffke, M Sivina, E Kim, L Wenserski, B Thiele, N Akyüz, C Falker-Gieske, D Statovci, A Oberle, T Thenhausen, A Krohn-Grimberghe, C Bokemeyer, N Jain, Z Estrov, A Ferrajoli, W Wierda, M Keating, JA Burger, M Binder |
OncoImmunology | 2017 |
|
Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections: PHAGE THERAPY FOR PROSTHETIC JOINT INFECTION
ZZ Akanda, M Taha, H Abdelbary |
Journal of orthopaedic research : official publication of the Orthopaedic Research Society | 2017 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)